Late term tolerance in head neck cancer patients irradiated in the IMRT era

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Studer, Gabriela ^a   Linsenmeier, Claudia ^a   Riesterer, Oliver ^a   Najafi, Yousef ^a   Brown, Michelle ^a   Yousefi, Bita ^a   Bredell, Marius ^a   Huber, Gerhard ^a   Schmid, Stephan ^b   Studer, Stephan ^a   Zwahlen, Roger ^c   Rordorf, Tamara ^a   Glanzmann, Christoph ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Otorhinolaryngology Head and Neck Surgery   (Switzerland)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Grade 3 4 late effects; IMRT and late term effects; IMRT tolerance; Late term tolerance; Persistent late term effects

Indexed keywords

CETUXIMAB; CISPLATIN; CONTRAST MEDIUM;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNGECTOMY; LARYNX EDEMA; LOADING DRUG DOSE; LOCAL RECURRENCE FREE SURVIVAL; LOCOREGIONAL DISEASE CONTROL; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NECK DISSECTION; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; TREATMENT DURATION; TREATMENT RESPONSE; VOLUMETRIC MODULATED ARC THERAPY; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887515909     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-259     Document Type: Article

References (21)

1. Ben-David MA, Diamante M, Radawski JD, Vineberg KA, Stroup C, Murdoch-Kinch CA, Zwetchkenbaum SR, Eisbruch A. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys 2007, 68:396-402. 10.1016/j.ijrobp.2006.11.059, 2702207, 17321069.
2. Eisbruch A, Levendag PC, Feng FY, Teguh D, Lyden T, Schmitz PI, Haxer M, Noever I, Chepeha DB, Heijmen BJ. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 2007, 69:S40-42. 2801073, 17848291.
3. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011, 12:127-136. 10.1016/S1470-2045(10)70290-4, 3033533, 21236730.
4. Peponi E, Glanzmann C, Willi B, Huber G, Studer G. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol 2011, 6:1. 10.1186/1748-717X-6-1, 3027127, 21208415.
5. Studer G, Graetz KW, Glanzmann C. In response to Dr. Merav a. Ben-David et al. ("Lack of osteoradionecrosis of the mandible after IMRT," Int J radiat oncol biol phys 2007). Int J Radiat Oncol Biol Phys 2007, 68:1583-1584.
6. Studer G, Studer SP, Zwahlen RA, Huguenin P, Grätz KW, Lütolf UM, Glanzmann C. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 2006, 182:283-288. 10.1007/s00066-006-1477-0, 16673062.
7. Wang X, Hu C, Eisbruch A. Organ-sparing radiation therapy for head and neck cancer. Nat Rev Clin Oncol 2011, 8:639-648. 10.1038/nrclinonc.2011.106, 21788974.
8. Studer G, Brown M, Salgueiro EB, Schmückle H, Romancuk N, Winkler G, Lee SJ, Sträuli A, Kissling B, Dummer R, Glanzmann C. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT. Int J Radiat Oncol Biol Phys 2011, 81:110-117. 10.1016/j.ijrobp.2010.05.018, 20732757.
9. Glanzmann C, Gratz KW. Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors. Radiother Oncol 1995, 36:94-100. 10.1016/0167-8140(95)01583-3, 7501817.
10. Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 2002, 28:65-74. 10.1053/ctrv.2002.0254, 12027415.
11. Studer G, Glanzmann C, Studer SP, Grätz KW, Bredell M, Locher M, Lütolf UM, Zwahlen RA. Risk-adapted dental care prior to intensity-modulated radiotherapy (IMRT). Schweiz Monatsschr Zahnmed 2011, 121:216-229.
12. Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006, 66:445-53. 10.1016/j.ijrobp.2006.05.002, 16839705.
13. Eisbruch A, Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, Teknos TN, Anzai Y, Marsh LH, Martel MK, Ten Haken RK, Wolf GT, Ship JA. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg 1999, 53:271-275.
14. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7-16. 10.1016/S0360-3016(00)00663-5, 10924966.
15. Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thöni A, Ozsahin M, Bernier J, Töpfer M, Kann R, Meier UR, Thum P, Bieri S, Notter M, Lombriser N, Glanzmann C. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004, 22:4665-4673. 10.1200/JCO.2004.12.193, 15534360.
16. Studer G, Gratz KW, Glanzmann C. Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlenther Onkol 2004, 180:233-240. 10.1007/s00066-004-1171-z, 15057434.
17. de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Stambuk H, Pfister D, Kraus D, Shaha A, Shah J, Lee NY. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the memorial Sloan-Kettering cancer center experience. Int J Radiat Oncol Biol Phys 2006, 64:363-373. 10.1016/j.ijrobp.2005.03.006, 15925451.
18. Debnam JM, Garden AS, Ginsberg LE. Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findings. AJNR Am J Neuroradiol 2008, 29:558-562. 10.3174/ajnr.A0886, 18202241.
19. Platteaux N, Dirix P, Hermans R, Nuyts S. Brachial plexopathy after chemoradiotherapy for head and neck squamous cell carcinoma. Strahlenther Onkol 2010, 186:517-520. 10.1007/s00066-010-2099-0, 20814659.
20. Pak D, Vineberg K, Feng F, Ten Haken RK, Eisbruch A. Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms. Int J Radiat Oncol Biol Phys 2012, 83:1528-1533. 10.1016/j.ijrobp.2011.10.052, 3481166, 22284690.
21. Fokkema M, den Hartog AG, van Lammeren GW, Bots ML, Pasterkamp G, Vink A, Moll FL, de Borst GJ. Radiation-induced carotid stenotic lesions have a more stable phenotype than de novo atherosclerotic plaques. Eur J Vasc Endovasc Surg 2012, 43:643-648. 10.1016/j.ejvs.2012.02.023, 22436263.